1. Home
  2. SINT vs GLMD Comparison

SINT vs GLMD Comparison

Compare SINT & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SINT
  • GLMD
  • Stock Information
  • Founded
  • SINT 1996
  • GLMD 2000
  • Country
  • SINT United States
  • GLMD Israel
  • Employees
  • SINT N/A
  • GLMD N/A
  • Industry
  • SINT Medical/Dental Instruments
  • GLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SINT Health Care
  • GLMD Health Care
  • Exchange
  • SINT Nasdaq
  • GLMD Nasdaq
  • Market Cap
  • SINT 4.3M
  • GLMD 4.5M
  • IPO Year
  • SINT 2014
  • GLMD 2014
  • Fundamental
  • Price
  • SINT $3.10
  • GLMD $2.70
  • Analyst Decision
  • SINT Hold
  • GLMD
  • Analyst Count
  • SINT 1
  • GLMD 0
  • Target Price
  • SINT N/A
  • GLMD N/A
  • AVG Volume (30 Days)
  • SINT 32.1K
  • GLMD 25.9K
  • Earning Date
  • SINT 03-26-2025
  • GLMD 11-14-2024
  • Dividend Yield
  • SINT N/A
  • GLMD N/A
  • EPS Growth
  • SINT N/A
  • GLMD N/A
  • EPS
  • SINT N/A
  • GLMD N/A
  • Revenue
  • SINT $3,247,000.00
  • GLMD N/A
  • Revenue This Year
  • SINT $18.23
  • GLMD N/A
  • Revenue Next Year
  • SINT N/A
  • GLMD N/A
  • P/E Ratio
  • SINT N/A
  • GLMD N/A
  • Revenue Growth
  • SINT 30.40
  • GLMD N/A
  • 52 Week Low
  • SINT $2.01
  • GLMD $2.56
  • 52 Week High
  • SINT $46.00
  • GLMD $23.80
  • Technical
  • Relative Strength Index (RSI)
  • SINT 42.35
  • GLMD 37.61
  • Support Level
  • SINT $2.95
  • GLMD $2.66
  • Resistance Level
  • SINT $3.26
  • GLMD $3.45
  • Average True Range (ATR)
  • SINT 0.22
  • GLMD 0.18
  • MACD
  • SINT -0.01
  • GLMD -0.02
  • Stochastic Oscillator
  • SINT 33.33
  • GLMD 0.61

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Share on Social Networks: